What Do HCPs Want from Pharma?

In a pharma landscape increasingly shaped by digital transformation and information overload, a new joint report from Impiricus and CMI Media Group offers a timely look into what HCPs actually want from pharma brands.

Based on an SMS-deployed survey of physicians and advanced practice providers across key specialties, the report surfaces candid insights into how healthcare professionals (HCPs) want, and need, to collaborate with pharmaceutical companies in 2025.

At a time when providers are grappling with soaring patient expectations and compressed clinical workflows, the message from the field is clear: support must be timely, targeted, and above all – useful.

HCPs Want Clear Education and Practical Support

Survey results show that 43% of HCPs want pharma to prioritize educational support, particularly in the form of accessible clinical data, real-world evidence, and updated treatment guidelines. Financial and coverage assistance ranked a close second, at 39%, underscoring a continuing frustration with affordability and insurance complexity.

The report includes perspectives from frontline clinicians emphasizing a need for actionable insights delivered through efficient platforms. As one dermatologist from California stated:

“Offering AI-driven decision support tools, personalized treatment recommendations, and streamlined access to drug information would be highly beneficial. Additionally, enhanced collaboration through digital platforms and expert consultations could...